EUVIMEDEUVIMED entdecken
Crossref

The ovarian hyperstimulation that truly matters: Admissions, severity and prevention strategies

Chase Medwin iD, Genia Rozen iD, Franca Agresta, Nassar Nassar, Alex Polyakov iD

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2023-08 · 63 (4) · 583-587

DOI: 10.1111/ajo.13688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, online erschienen am 16.04.2023. Verfasst von Chase Medwin und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Royal Women's Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Ovarian Hyperstimulation Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ovarian hyperstimulation syndrome (OHSS) is a common but serious complication of in vitro fertilisation. Despite available strategies to reduce OHSS incidence, a small proportion of patients will develop the clinically significant disease with substantial morbidity. Efforts toward better understanding and the prevention of severe disease are required to improve patient outcomes.

Aims

The aims are to: (1) formulate clinically relevant OHSS classification for inpatient settings and data collection/reporting; (2) estimate OHSS prevalence requiring hospital admission in Victoria; and (3) determine the extent of OHSS preventability with clinical strategies. Materials and Methods This retrospective cohort study included all OHSS admissions in a tertiary referral centre, January 2016–December 2021, which included approximately 40% of all cases of hospitalisation for OHSS in the State of Victoria. Patient characteristics, treatment regimes, fertility treatment outcomes, timing classification, and clinical markers of disease severity were studied. Patients were classified as having mild, moderate, or severe OHSS with a novel inpatient classification system.

Results

Of 199 OHSS cases presenting to the tertiary institution, 107 were classified as moderate/severe, with no significant difference between age, body mass index, length of stimulation and follicle number between mild/moderate and severe groups. There were more cases of early hyperstimulation (137) compared to late (62) presentation, of which 53% were severe. The average length of stay overall was 3.1 days, and 5.2 days for severe presentations. In 15% of severe cases, an agonist trigger was used.

Conclusions

The overall prevalence of OHSS requiring hospital admission appears to be low (approximately 0.6% of all stimulated cycles). Established risk factors may not accurately predict clinically relevant OHSS risk. Further monitoring, clinician and patient education are required to minimise the risk of significant OHSS that results in hospital admissions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian Hyperstimulation SyndromeFemaleHumansRetrospective StudiesFertilization in VitroRisk FactorsIncidenceOvulation Induction

Stichwörter der Autor:innen

IVFcomplicationsinfertilityovarian hyperstimulation syndromeprevention

Autor:innen und Institutionen

  • The Royal Women's Hospital, Melbourne, Victoria, Australia.
  • Reproductive Services Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia.
  • Melbourne IVF, Melbourne, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.
  • Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Chase Medwin, Genia Rozen, Alex Polyakov

Zitieren

APA

Medwin, C., Rozen, G., Agresta, F., Nassar, N., & Polyakov, A. (2023). The ovarian hyperstimulation that truly matters: Admissions, severity and prevention strategies. Australian and New Zealand Journal of Obstetrics and Gynaecology, 63(4), 583-587. https://doi.org/10.1111/ajo.13688

Vancouver

Medwin C, Rozen G, Agresta F, Nassar N, Polyakov A. The ovarian hyperstimulation that truly matters: Admissions, severity and prevention strategies. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2023;63(4):583-587. doi:10.1111/ajo.13688

BibTeX
@article{Medwin2023,
  author = {Medwin, Chase and Rozen, Genia and Agresta, Franca and Nassar, Nassar and Polyakov, Alex},
  title = {The ovarian hyperstimulation that truly matters: Admissions, severity and prevention strategies},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2023},
  volume = {63},
  number = {4},
  pages = {583--587},
  doi = {10.1111/ajo.13688}
}
Kostenlos starten →